ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Hofseth Biocare Asa

Hofseth Biocare Asa (0Q6H)

2,00
0,00
(0,00%)
Geschlossen 06 Januar 5:30PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
2,00
Gebot
0,00
Fragen
0,00
Volumen
0,00
0,00 Tagesbereich 0,00
2,00 52-Wochen-Bereich 2,00
Marktkapitalisierung
Handelsende
2,00
Handelsbeginn
-
Letzte Trade
(O)
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
2.664
Ausgegebene Aktien
395.081.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-7,41
Gewinn pro Aktie (EPS)
-0,27
Erlöse
218,51M
Nettogewinn
-106,68M

Über Hofseth Biocare Asa

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Alesund, Nor
Gegründet
-
Hofseth Biocare Asa is listed in the Pharmaceutical Preparations sector of the Londoner Börse with ticker 0Q6H. The last closing price for Hofseth Biocare Asa was kr2,00. Over the last year, Hofseth Biocare Asa shares have traded in a share price range of kr 2,00 to kr 2,00.

Hofseth Biocare Asa currently has 395.081.000 shares in issue. The market capitalisation of Hofseth Biocare Asa is kr790,16 million. Hofseth Biocare Asa has a price to earnings ratio (PE ratio) of -7.41.

0Q6H Neueste Nachrichten

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION

Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA ("HBC") has today purchased 700,000 shares in HBC...

Hofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacity

Hofseth Biocare ASA: Commences the project for a second hydrolysis plant in Norway to triple capacity Hofseth BioCare ASA ("HBC" or the "Company", and together with its consolidated subsidiaries...

Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT

Hofseth Biocare ASA: THIRD QUARTER 2024 FINANCIAL REPORT HBC had gross operating revenues of NOK 67.9m (49.9m) in the third quarter and NOK 200.6m (171.1m) in the first nine months. The operating...

Hofseth Biocare ASA: CFO RESIGNATION

Hofseth Biocare ASA: CFO RESIGNATION Christel Elise Kanli has decided to step down as Chief Financial Officer (CFO) of Hofseth BioCare ASA (“HBC”) to pursue opportunities outside of the company...

Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT

Hofseth Biocare ASA: HBC IMMUNOLOGY COMPLETES IN VIVO DRUG LEAD STUDIES FOR PROSTATE CANCER TREATMENT Ålesund, Norway, 8 October 2024. HBC Immunology (HBCI) is pleased to announce the successful...

Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT

Hofseth Biocare ASA: SECOND QUARTER AND HALF YEAR 2024 FINANCIAL REPORT HBC had gross operating revenues of NOK 80.4m (76.4m) in the second quarter and NOK 132.8m (121.2m) for the half year...

Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY

Hofseth Biocare ASA: GROUNDBREAKING STUDY REVEALS HOFSETH BIOCARE’S FULL SPECTRUM OMEGAS OMEGO SUPPORTS COVID-19 RECOVERY Ålesund, Norway, 14 August, 2024 - Hofseth BioCare (HBC), a leader in...

Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc.

Hofseth Biocare ASA: HBC discovers new drug candidate for asthma and transfers it to HBC Immunology Inc. Ålesund, 02.07.24, Hofseth BioCare ASA ("HBC" or the "Company"), a global leader in marine...

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY Hofseth BioCare ASA (HBC) is delighted to announce the appointment of Lithy One-Health Group Technology Co. Ltd...

Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT

Hofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORT The first quarter of 2024 continued on the positive trend for HBC. Sales revenues came in at NOK 52m vs NOK 44m last year, a growth of 17...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10022200DE
4002226452DE
120022226642DE
260022211802DE
520022211802DE
156002226592DE
2600022226352DE

0Q6H - Frequently Asked Questions (FAQ)

What is the current Hofseth Biocare Asa share price?
The current share price of Hofseth Biocare Asa is kr 2,00
How many Hofseth Biocare Asa shares are in issue?
Hofseth Biocare Asa has 395.081.000 shares in issue
What is the market cap of Hofseth Biocare Asa?
The market capitalisation of Hofseth Biocare Asa is NOK 790,16M
What is the 1 year trading range for Hofseth Biocare Asa share price?
Hofseth Biocare Asa has traded in the range of kr 2,00 to kr 2,00 during the past year
What is the PE ratio of Hofseth Biocare Asa?
The price to earnings ratio of Hofseth Biocare Asa is -7,41
What is the cash to sales ratio of Hofseth Biocare Asa?
The cash to sales ratio of Hofseth Biocare Asa is 3,62
What is the reporting currency for Hofseth Biocare Asa?
Hofseth Biocare Asa reports financial results in NOK
What is the latest annual turnover for Hofseth Biocare Asa?
The latest annual turnover of Hofseth Biocare Asa is NOK 218,51M
What is the latest annual profit for Hofseth Biocare Asa?
The latest annual profit of Hofseth Biocare Asa is NOK -106,68M
What is the registered address of Hofseth Biocare Asa?
The registered address for Hofseth Biocare Asa is HAVNEGATA 11, ALESUND, 6005
What is the Hofseth Biocare Asa website address?
The website address for Hofseth Biocare Asa is www.hofsethbiocare.com
Which industry sector does Hofseth Biocare Asa operate in?
Hofseth Biocare Asa operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TCFTheracryf Plc
0,725p
(38,10%)
7,56M
NMTNeometals Ltd
3,50p
(27,27%)
346,81k
SCHOScholium Group Plc
44,00p
(25,71%)
30,65k
FABFusion Antibodies Plc
10,15p
(24,54%)
3,34M
PYXPyx Resources Limited
3,49p
(22,24%)
8,43k
TM1Technology Minerals Plc
0,125p
(-24,24%)
37,21M
QUIZQuiz Plc
0,70p
(-18,60%)
3,67M
SYMESupply@me Capital Plc
0,003p
(-17,81%)
168,35M
OBDOxford Biodynamics Plc
1,20p
(-14,29%)
827,83k
ZENZenith Energy Ltd.
5,25p
(-13,93%)
5,39M
TRPTower Resources Plc
0,0395p
(5,33%)
539,51M
CPXCap-xx Limited
0,1825p
(1,39%)
494M
NTVONativo Resources Plc
0,0019p
(0,00%)
320,16M
DGIDg Innovate Plc
0,0225p
(-13,46%)
208,21M
ENETEthernity Networks Ltd
0,1125p
(2,27%)
207,56M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock